news aktuell GmbH

Flu tests from R-Biopharm also detect new virus variants

Share
Detect reliably the current flu virus variants: The RIDA®GENE flu assays from R-Biopharm
Photo: Getty Images
Detect reliably the current flu virus variants: The RIDA®GENE flu assays from R-Biopharm Photo: Getty Images

Darmstadt, November 25, 2022 – The flu season has begun and different virus variants are also circulating in Germany. With the flu tests from biotechnology company R-Biopharm, patients quickly have certainty: Its RIDA®GENE Flu assays also reliably detect the two novel variants. The company made the announcement with regard to influenza A H1N1pdm09, which is circulating primarily in the United Kingdom, and the H3N2 subtype, which was rampant in Denmark in the spring and is currently dominating influenza activity in Germany.

"Mutations in the target gene (MP gene) can affect the diagnostic performance of influenza screening assays, producing false-negative test results," explains Dr. Andreas Simons, Head of Product Management at R-Biopharm. " Alignments of the detection systems we used with the described sequences of the two novel virus variants showed no mismatches. Their reliable detection is not affected by the described mutations."

This means laboratories can continue to reliably confirm or rule out influenza infections using R-Biopharm's RIDA®GENE (PG0505, PG0545, PG6825) assays. The tests are multiplex real-time RT-PCR for the direct qualitative detection of influenza viruses.

About R-Biopharm

R-Biopharm AG, located in Darmstadt, is one of Germany's leading biotechnology companies. Founded in 1988, the company is family-run in the second generation and considers itself as a pioneer for health and quality of life. Its aspiration: to provide the highest possible precision, safety, clarity and certainty in prevention, therapy and healing. To this end, R-Biopharm develops technologies, products and solutions for Clinical Diagnostics, Nutrition Care and Food and Feed Analytics – and does so in internationally recognized top quality. R-Biopharm is the world market leader for test systems in the field of allergen analysis. 

R-Biopharm unites research, development and sales under one roof in order to respond to ever new challenges with agile processes and to accompany the steadily growing world population into a new health era. The company is represented in more than 120 countries – through 29 subsidiaries and 120 distributors. It employs around 1,400 people worldwide (690 at its headquarters in Darmstadt) and was repeatedly recognized with the "Sustainability Award" for sustainable and profitable growth.

 

Press contact:

Simone Feiler

Head of Corporate Brand Communication

https://r-biopharm.com/de/

https://r-biopharm.com/de/kontakt/presse/

https://r-biopharm.com/de/news-presse/download-galerie/

R-Biopharm AG

An der neuen Bergstraße 17

64297 Darmstadt

Phone: 0 61 51 - 81 02-538

Mobile: 0 160 - 55 273 60

Fax: 0 61 51 - 81 02-40

Email: s.feiler@r-biopharm.de

Images

Detect reliably the current flu virus variants: The RIDA®GENE flu assays from R-Biopharm
Photo: Getty Images
Detect reliably the current flu virus variants: The RIDA®GENE flu assays from R-Biopharm Photo: Getty Images
Download

About news aktuell GmbH

news aktuell GmbH
news aktuell GmbH
Mittelweg 144
20148 Hamburg

+49 (0)40 4113-32589http://www.newsaktuell.de

As wholly owned subsidiary of dpa, news aktuell provides business and organizations with effective access to media and consumers. Via the smart tools ots and zimpel, PR content accesses all media formats, including classical print, high click-rate online portals and social networks. In addition, news aktuell publishes all its customers’ PR content on www.presseportal.de, one of the PR portals with the greatest reach in Germany. By this means, all the relevant multipliers are reached globally, from editors, via digital influencers right up to specialist bloggers and interested consumers. news aktuell has been on the market since 1989. The company, with a staff complement of more than 135, has its headquarters in Hamburg. Other offices are in Berlin, Dusseldorf, Frankfurt und Munich.

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

WEF 2023: ProjectTogether receives the Schwab Foundation Collective Social Innovation Award recognizing the power of collaborative action19.1.2023 07:51:54 CET | Pressmeddelande

Davos, January 18, 2023. The non-profit organization ProjectTogether received the Schwab Foundation’s Collective Social Innovation Award 2023 at the World Economic Forum (WEF) in Davos. As the first award winner in this category, the Schwab Foundation recognizes ProjectTogether for its new approach to orchestrate collaborative action between bottom-up innovators and top-down institutions to create impact. At the award ceremony, founder Philipp von der Wippel explained the vision of a pan-European approach to collective action—across all sectors and political levels—to tackle ongoing and looming societal challenges.

Recession to slow Germany's advertising market in 2023 / The annual growth forecast by the JOM Group foresees an increase of just 0.5 per cent for the 2023 advertising market in Germany12.1.2023 08:06:05 CET | Pressmeddelande

Hamburg, January 11, 2023. The German advertising market could have succeeded in returning to its pre-Covid-19 level as early as in 2022, and then pushed on to new heights in 2023. However, as is generally well known, external factors like the Ukraine conflict and persisting supply bottlenecks have prevented this development. The experts from the JOM Group, agency for hybrid marketing communication, therefore assess that net advertising investment in 2022 only increased by some 1.2 per cent. After a good start to the year, investments fell significantly below the level of the previous year, especially during the second half of the year. The JOM Group is forecasting even weaker growth of around 0.5 per cent for 2023. That would bring the total volume in the market to around 22.7 billion euro. Stronger focus on sales in communication In a weak economic environment, household consumption will also continue to decline in the coming year. In combination with continued high inflation rates,

#Thankyou: NPO One Life launches the first Vienna International Pride Awards11.1.2023 10:00:00 CET | Press release

Austrian NPO One Life launches the Vienna International Pride Awards It is the first global event and campaign to recognize LGBTIQ+ equality change makers #ThankYou campaign leading to the Awards kicks off on International Thank You Day It's time to say “Thank You”: on International Thank You Day - January 11, 2023, Vienna-based NPO, One Life, announces the launch of the Vienna International Pride Awards, a new annual campaign and event to thank and recognize the vital world of LGBTIQ+ equality heroes around the world. The idea for the International Pride Awards came from Tony Gregory, an award-winning television director. He describes the guiding vision of the Vienna International Pride Awards as: “A world where the rainbow of differences and preferences of LGBTIQ+ people are not only tolerated, but deeply and universally accepted and cherished”. Official campaign mission partners are the United Nations Development Program (UNDP), the MTV Staying Alive Foundation and ILGA-World (the I

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom